Annovis_Corp_Image.png
Annovis Bio Receives Institutional Review Board Approval to Initiate 15 Site Phase 2 Study in 68 Parkinson’s and Alzheimer’s Patients
July 07, 2020 06:45 ET | Annovis Bio Inc.
BERWYN, Pa., July 07, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other...
Statement From Irving Shipbuilding
May 30, 2019 17:10 ET | J.D. Irving, Limited
HALIFAX, Nova Scotia, May 30, 2019 (GLOBE NEWSWIRE) -- We fully respect all journalists’ responsibility to ask questions.  Irving Shipbuilding has given dozens of interviews and has invited media to...
Déclaration d’Irving Shipbuilding
May 30, 2019 17:10 ET | J.D. Irving, Limited
HALIFAX, Nouvelle-Écosse, 30 mai 2019 (GLOBE NEWSWIRE) -- Nous respectons entièrement la liberté des journalistes, qui ont le droit de poser des questions. Irving Shipbuilding a donné des...
lexingtonbiologo.jpg
Lexington Receives Approval to Commence Clinical Study
January 24, 2018 09:00 ET | Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
lexingtonbiologo.jpg
Lexington Completes IRB Submission in Preparation for Clinical Study
January 18, 2018 09:00 ET | Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device...
SANUWAVE Reports Second Quarter 2012 Financial Results and Provides a Business Update
August 08, 2012 17:00 ET | SANUWAVE Health, Inc.
ALPHARETTA, Ga., Aug. 8, 2012 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today reported financial results for the three and six months ended June 30, 2012 and provided a business...